Thromb Haemost 1999; 82(05): 1557-1558
DOI: 10.1055/s-0037-1614874
Letters to the Editor
Schattauer GmbH

Type 2B von Willebrand’s Disease and Angiodysplasia

Mark S. Hertzberg
1   From the Department of Haematology, Westmead Hospital, Westmead, Australia
,
David A. Facey
1   From the Department of Haematology, Westmead Hospital, Westmead, Australia
,
Emmanuel J. Favaloro
1   From the Department of Haematology, Westmead Hospital, Westmead, Australia
,
Jerry Koutts
1   From the Department of Haematology, Westmead Hospital, Westmead, Australia
› Author Affiliations
Further Information

Publication History

Received 22 March 1999

Accepted 15 April 1999

Publication Date:
09 December 2017 (online)

 

 
  • References

  • 1 Ramsay DM, Buist TAS, Macleod DAD, Heading RC. Persistent gastrointestinal bleeding due to angiodysplasia of the gut in von Willebrand’s disease. Lancet 1976; 1: 275-8.
  • 2 Ahr DJ, Rickles FR, Hoyer LW, O’Leary DS, and Conrad ME. Von Willebrand’s disease and hemorrhagic telangiectasia: association of two complex disorders of hemostasis resulting in life-threatening hemorrhage. Am J Med. 1977; 62: 452-8.
  • 3 Conlon CL, Weinger RS, Cimo PL, Moake JL, and Olson JD. Telangiectasia and von Willebrand’s disease in two families. Ann Int Med 1978; 89: 921-4.
  • 4 Hanna W, McCarroll D, Lin D, Chua W, McDonald TP, Chen J, Congdon C, Lange RD. A study of a Caucasian family with variant von Willebrand’s disease in association with vascular telangiectasia and haemoglobinopathy. Thromb Haemost 1984; 51: 275-8.
  • 5 Iannuzzi MC, Hidaka N, Boehnke M, Bruck ME, Hanna WT, Collins FS, and Ginsburg D. Analysis of the relationship of von Willebrand disease (vWD) and hereditary hemorrhagic telangiectasia and identification of a potential type IIa vWD mutation (Ile865 to Thr). Am J Hum Genet 1991; 48: 757-63.
  • 6 McAllister KA, Baldwin MA, Thukkani AK, Gallione CJ, Berg JN, Porteous ME, Guttmacher AE, and Marchuk DA. Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum Mol Genet 1995; 4: 1983-5.
  • 7 Johnson DW, Berg JN, Gallione CJ, McAllister KA, Warner JP, Helmbold EA, Markel DS, Jackson CE, Porteous ME, and Marchuk DA. A second locus for hereditary hemorrhagic telangiectasia mapped to chromosome 12. Genome Res 1995; 5: 21-8.